Loading...
Loading...
India's lenvatinib imports from JAPAN total $1.2M across 12 shipments from 2 foreign suppliers. EISAI CO. LTD. leads with $943.8K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for lenvatinib — a concentrated sourcing relationship with select suppliers from JAPAN.

EISAI CO. LTD. is the leading Lenvatinib supplier from JAPAN to India, with import value of $943.8K across 11 shipments. The top 5 suppliers — EISAI CO. LTD., EISAI CO. LIMITED — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | EISAI CO. LTD. | $943.8K | 11 | 80.2% |
| 2 | EISAI CO. LIMITED | $232.8K | 1 | 19.8% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED | $1.2M | 12 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Lenvatinib suppliers from JAPAN to India include EISAI CO. LTD., EISAI CO. LIMITED. The leading supplier is EISAI CO. LTD. with import value of $943.8K USD across 11 shipments. India imported Lenvatinib worth $1.2M USD from JAPAN in total across 12 shipments.
India imported Lenvatinib worth $1.2M USD from JAPAN across 12 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Lenvatinib sourced from JAPAN include EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED. The largest buyer is EISAI PHARMACEUTICALS INDIA PRIVATE LIMITED with $1.2M in imports across 12 shipments.
The total value of Lenvatinib imports from JAPAN to India is $1.2M USD, across 12 shipments and 2 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
12 Verified Shipments
2 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists